Arbutus Biopharma Corp. (ABUS)
4.45
-0.11
(-2.41%)
USD |
NASDAQ |
Oct 02, 16:00
4.475
+0.02
(+0.56%)
After-Hours: 20:00
Arbutus Biopharma Max Drawdown (5Y) : 84.78% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 84.78% |
| August 31, 2026 | 84.78% |
| July 31, 2026 | 84.78% |
| June 30, 2026 | 84.78% |
| May 31, 2026 | 84.78% |
| April 30, 2026 | 84.78% |
| March 31, 2026 | 84.78% |
| February 28, 2026 | 84.78% |
| January 31, 2026 | 84.78% |
| December 31, 2025 | 84.78% |
| November 30, 2025 | 84.78% |
| October 31, 2025 | 84.78% |
| September 30, 2025 | 84.78% |
| August 31, 2025 | 84.78% |
| July 31, 2025 | 84.78% |
| June 30, 2025 | 85.83% |
| May 31, 2025 | 89.10% |
| April 30, 2025 | 91.95% |
| March 31, 2025 | 95.31% |
| February 28, 2025 | 95.31% |
| January 31, 2025 | 95.31% |
| December 31, 2024 | 95.31% |
| November 30, 2024 | 95.31% |
| October 31, 2024 | 95.31% |
| September 30, 2024 | 96.69% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.69% |
| July 31, 2024 | 96.69% |
| June 30, 2024 | 96.69% |
| May 31, 2024 | 96.69% |
| April 30, 2024 | 96.69% |
| March 31, 2024 | 96.69% |
| February 29, 2024 | 96.69% |
| January 31, 2024 | 96.69% |
| December 31, 2023 | 96.69% |
| November 30, 2023 | 96.69% |
| October 31, 2023 | 96.69% |
| September 30, 2023 | 96.69% |
| August 31, 2023 | 96.69% |
| July 31, 2023 | 96.69% |
| June 30, 2023 | 96.69% |
| May 31, 2023 | 96.69% |
| April 30, 2023 | 96.69% |
| March 31, 2023 | 96.69% |
| February 28, 2023 | 96.69% |
| January 31, 2023 | 96.69% |
| December 31, 2022 | 96.69% |
| November 30, 2022 | 96.69% |
| October 31, 2022 | 96.69% |
| September 30, 2022 | 96.69% |
| August 31, 2022 | 96.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Insmed, Inc. | 63.30% |
| Pfizer Inc. | 58.95% |
| Gossamer Bio, Inc. | 99.13% |
| Legend Biotech Corp. | 78.24% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.240 |
| Beta (5Y) | 0.7637 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 42.93% |
| Historical Sharpe Ratio (5Y) | -0.0372 |
| Historical Sortino (5Y) | -0.072 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 15.09% |